NCT00006047View on ClinicalTrials.gov

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

Oral Etoposide

DRUG

Oral 9-Nitrocamptothecin

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Astex Pharmaceuticals, Inc.

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER